Tamoxifen acts on Trypanosoma cruzi sphingolipid pathway triggering an apoptotic death process.
暂无分享,去创建一个
F. Garcia-Bournissen | V. Duschak | L. Fichera | A. Couto | M. Esteva | M. Landoni | L. L. Soprano | Tamara Piñero | Malena Landoni
[1] A. Silber,et al. Tamoxifen inhibits the biosynthesis of inositolphosphorylceramide in Leishmania , 2018, International journal for parasitology. Drugs and drug resistance.
[2] V. Duschak. Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period. , 2016, Recent patents on anti-infective drug discovery.
[3] Cristiana T. Trinconi,et al. Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis. , 2016, The Journal of antimicrobial chemotherapy.
[4] L. Agredano-Moreno,et al. Ultrastructural and physiological changes induced by different stress conditions on the human parasite Trypanosoma cruzi , 2016, Cell Stress and Chaperones.
[5] Cristiana T. Trinconi,et al. Leishmania is not prone to develop resistance to tamoxifen , 2015, International journal for parasitology. Drugs and drug resistance.
[6] Chunfa Huang,et al. Lipid Metabolism, Apoptosis and Cancer Therapy , 2015, International journal of molecular sciences.
[7] Cristiana T. Trinconi,et al. Combination Therapy with Tamoxifen and Amphotericin B in Experimental Cutaneous Leishmaniasis , 2014, Antimicrobial Agents and Chemotherapy.
[8] T. Urményi,et al. Molecular and functional characterization of the ceramide synthase from Trypanosoma cruzi. , 2012, Molecular and biochemical parasitology.
[9] R. Docampo,et al. Inositolphosphoceramide Metabolism in Trypanosoma cruzi as Compared with other Trypanosomatids , 2011, The Journal of eukaryotic microbiology.
[10] P. Bastien,et al. Targeting essential pathways in trypanosomatids gives insights into protozoan mechanisms of cell death , 2010, Parasites & Vectors.
[11] D. C. Miguel,et al. The anticancer drug tamoxifen is active against Trypanosoma cruzi in vitro but ineffective in the treatment of the acute phase of Chagas disease in mice. , 2010, Memorias do Instituto Oswaldo Cruz.
[12] Renata L. S. Goncalves,et al. The effects on Trypanosoma cruzi of novel synthetic naphthoquinones are mediated by mitochondrial dysfunction. , 2009, Free radical biology & medicine.
[13] W. de Souza,et al. Subcellular proteomics of Trypanosoma cruzi reservosomes , 2009, Proteomics.
[14] A. Vercesi,et al. Mitochondrial calcium overload triggers complement-dependent superoxide-mediated programmed cell death in Trypanosoma cruzi. , 2009, The Biochemical journal.
[15] N. Galanti,et al. Natural programmed cell death in T. cruzi epimastigotes maintained in axenic cultures , 2008, Journal of cellular biochemistry.
[16] D. C. Miguel,et al. Tamoxifen Is Effective in the Treatment of Leishmania amazonensis Infections in Mice , 2008, PLoS neglected tropical diseases.
[17] M. J. Soares,et al. Mitochondrial disruption and DNA fragmentation in Trypanosoma cruzi induced by naphthoimidazoles synthesized from β-lapachone , 2007, Parasitology Research.
[18] F. Hsu,et al. Leishmania salvage and remodelling of host sphingolipids in amastigote survival and acidocalcisome biogenesis , 2005, Molecular microbiology.
[19] B. Zingales,et al. Trypanosoma cruzi: metabolic labeling of trypomastigote sialoglycolipids , 1985, Experientia.
[20] E. F. Merino,et al. Glycosphingolipids in Plasmodium falciparum. Presence of an active glucosylceramide synthase. , 2004, European journal of biochemistry.
[21] S. Mandlekar,et al. Mechanisms of tamoxifen-induced apoptosis , 2001, Apoptosis.
[22] A. Ruiz,et al. Trypanosoma cruzi: methoprene is a potent agent to sterilize blood infected with trypomastigotes. , 2002, Experimental parasitology.
[23] G. Pohlentz,et al. Monohexosylceramides of Trypanosoma dionisii. , 1996, The Journal of eukaryotic microbiology.
[24] R. A. Klein,et al. Structural characterization of neutral glycosphingolipids from Trypanosoma cruzi. , 1992, Molecular and biochemical parasitology.
[25] J. Cazzulo,et al. End products and enzyme levels of aerobic glucose fermentation in trypanosomatids. , 1985, Molecular and biochemical parasitology.
[26] L. Hogge,et al. Glycolipid components of epimastigote forms of Trypanosoma cruzi. , 1985, Comparative biochemistry and physiology. B, Comparative biochemistry.
[27] B. Zingales,et al. In vivo incorporation of palmitic acid and galactose in glycolipids of Trypanosoma cruzi epimastigotes. , 1985, Biochemistry international.
[28] J. G. Hirsch,et al. ULTRASTRUCTURE OF HUMAN LEUKOCYTES AFTER SIMULTANEOUS FIXATION WITH GLUTARALDEHYDE AND OSMIUM TETROXIDE AND "POSTFIXATION" IN URANYL ACETATE , 1968, Journal of Cell Biology.
[29] Z. Brener. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. , 1962, Revista do Instituto de Medicina Tropical de Sao Paulo.